Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

PURPOSE: Metastatic response to induction therapy for high-risk neuroblastoma is a prognostic factor. In the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN) HR-NBL-1 protocol, only patients with metastatic complete response (CR) or partial response (PR) with ≤ three abnorm...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoroso, Loredana, Erminio, Giovanni, Makin, Guy, Pearson, Andrew D. J., Brock, Penelope, Valteau-Couanet, Dominique, Castel, Victoria, Pasquet, Marlène, Laureys, Genevieve, Thomas, Caroline, Luksch, Roberto, Ladenstein, Ruth, Haupt, Riccardo, Garaventa, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784636/
https://www.ncbi.nlm.nih.gov/pubmed/28324923
http://dx.doi.org/10.4143/crt.2016.511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784636/
https://www.ncbi.nlm.nih.gov/pubmed/28324923
http://dx.doi.org/10.4143/crt.2016.511

Ejemplares similares